Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 3 (2016) THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT Abstract  PDF (Eng)  similar documents
S. R. Gilyarevskiy
"... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... of venous thromboembolism (VTE) compared with low molecular weight heparin (LMWH)/warfarin and other new ..."
 
Vol 12, No 6 (2016) Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis Abstract  PDF (Eng)  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..."
 
Vol 12, No 1 (2016) Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis Abstract  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..."
 
Vol 10, No 6 (2014) THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY Abstract  similar documents
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
"... Despite large number of known risk factors of venous thromboembolism (VTE) in cancer patients ..."
 
Vol 13, No 2 (2017) RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY Abstract  similar documents
. Editorial
"... 100 мг при длительной профилактике рецидивов тромбоза глубоких вен и тромбоэмболии легочной артерии. В ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... . In connection with the known disadvantages of warfarin use, the elaboration of new oral anticoagulants (NOAC ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..."
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
"...   favorable profile of drug  interaction in comparison with other new oral anticoagulants (NOAC). The basis ..."
 
Vol 13, No 5 (2017) Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells Abstract  similar documents
Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov
"... profile of drug interaction in comparison to other non-vitamin K antagonist oral anticoagulants (NOAC ..."
 
Vol 16, No 1 (2020) The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation Abstract  similar documents
A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva
"... in a nonrandomized observational study of new oral anticoagulants (NOAC) in real clinical practice. A history ..."
 
Vol 14, No 4 (2018) Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases Abstract  similar documents
O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin
"... anticoagulants (NOACs), previously known as new oral anticoagulants are used in the treatment and prevention ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... Venous thromboembolic (VTE) events are a major concern in large joints replacement leading ..."
 
Vol 12, No 4 (2016) The use of oral anticoagulants in patients with atrial fibrillation: cohort study data Abstract  similar documents
O. V. Gaisenok, A. S. Leonov
"... OAC (NOAC), prescription depending type AF and the reasons for their not-prescribing were studied ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
"... oral anticoagulants (NOAC): 1) none of the randomized controlled trials (RCTs) with NOAC (except ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova
"... controlled trials (RCTs) with NOAC (except for two RCTs with rivaroxaban – EINSTEIN-DVT and EINSTEIN-PE ..."
 
Vol 15, No 6 (2019) Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova
"... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..."
 
Vol 18, No 3 (2022) Risk of Venous Thromboembolic Complications in Patients with Atrial Fibrillation: a Systematic Review and Meta-analysis Abstract  PDF (Eng)  similar documents
A. A. Sokolova, A. A. Kudriavtseva, N. V. Kostokova, M. P. Zaikina, Z. A. Gebekova, D. A. Napalkov, I. A. Zolotukhin
"... between AF and VTE. Material and methods. Atrial fibrillation (AF) and atrial flutter (AFL) contribute ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... warfarin, 15% new oral anticoagulants (NOAC). The majority of patients received antiplatelet agents ..."
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..."
 
Vol 4, No 3 (2008) THE RUSSIAN DATA OF INTERNATIONAL ENDORSE REGISTER (EPIDEMIOLOGIC INTERNATIONAL DAY FOR THE EVALUATION OF PATIENTS AT RISK OF VENOUS THROMBOSIS IN ACUTE HOSPITAL CARE SETTING) Abstract  similar documents
V. A. Sulimov, S. M. Belentsov, N. I. Golovina, N. P. Dubrovnaja, K. P. Zhidkov, K. V. Yeliseyeva, P. O. Kazanchan, A. V. Redkin, G. V. Rodoman, I. L. Fridman, V. N. Shershnev
"... Aim. To estimate a risk factor frequency of venous thromboembolism (VTE) in patients urgently ..."
 
Vol 17, No 6 (2021) Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 Abstract  similar documents
I. S. Yavelov
"... VTE risk score with the addition of elevated in-hospital D-dimer  level. And the most well-studied ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"...   of new OAC (NOAC) also appeared. In Russia, dabigatran, rivaroxaban and apixaban have been registered ..."
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
"... oral anticoagulants (NOACs), 213 (49.6%) – warfarin, 156 (36.4%) – did not take any oral anticoagulant ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... .7%; Kolmogorov-Smirnov; p<0.05). Patients receiving new oral anticoagulants (NOAC) have better compliance ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... lately new oral anticoagulants (NOAC) are becoming more common for the prevention of thromboembolic ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... with venous thromboembolism (VTE). Material and methods. Economic evaluation was performed from a position ..."
 
Vol 20, No 1 (2024) A rare clinical case of pulmonary artery sarcoma Abstract  similar documents
G. R. Bikbaeva, A. N. Kovalskaya, A. P. Rodin, G. V. Salamov, T. V. Pavlova, D. V. Duplyakov
 
Vol 16, No 5 (2020) Thrombolytic Therapy in Normotensive Patients with Pulmonary Embolism (Data from the Retrospective Study) Abstract  similar documents
N. A. Сherepanova, I. S. Mullova, A. R. Kiselev, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov
"... Актуальность. Пациентам с тромбоэмболией легочной артерии (ТЭЛА) в состоянии шока или гипотензии ..."
 
Vol 12, No 4 (2016) Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation Abstract  similar documents
S. G. Kanorskii
 
Vol 18, No 2 (2022) Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region) Abstract  similar documents
N. N. Nikulina, Yu. V. Terekhovskaya, S. S. Yakushin
"... тромбоэмболией легочной артерии (ТЭЛА) в рутинной клинической практике. Материалы и методы. В течение 13 мес ..."
 
Vol 19, No 6 (2023) Pericarditis as an onset of cancer Abstract  similar documents
D. F. Mesitskaya, S. A. Panov, D. A. Andreev, A. N. Volovchenko, A. Sh. Dumikyan
"... не дала результата, состояние пациентки осложнилось рецидивирующей тромбоэмболией легочной артерией с ..."
 
Vol 5, No 1 (2009) GUIDELINES ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM Abstract  similar documents
Adam Torbicki, Arnaud Perrier, Stavros Konstantinides, Giancarlo Agnelli, Nazzareno Galie, Piotr Pruszczyk, Frank Bengel, Adrian J.B. Brady, Daniel Ferreira, Uwe Janssens, Walter Klepetko, Eckhard Mayer, Martine Remy-Jardin, Jean-Pierre Bassand, M. O. Evseev
 
Vol 5, No 2 (2009) GUIDELINES ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM Abstract  similar documents
Adam Torbicki, Arnaud Perrier, Stavros Konstantinides, Giancarlo Agnelli, Nazzareno Galie, Piotr Pruszczyk, Frank Bengel, Adrian J.B. Brady, Daniel Ferreira, Uwe Janssens, Walter Klepetko, Eckhard Mayer, Martine Remy-Jardin, Jean-Pierre Bassand, M. O. Evseev
 
Vol 7, No 1 (2011) RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE Abstract  similar documents
R. Rajan, R. Natarajan, G. Vijayaraghavan
"... Тромбоэмболия легочной артерии (ТЭЛА) — это жизнеугрожающее состояние, которое может привести к ..."
 
Vol 15, No 1 (2019) Prognostic Value of ECG in Patients with Pulmonary Embolism Abstract  similar documents
I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov
"... тромбоэмболией легочной артерии (ТЭЛА). Материал и методы. В исследование было включено 472 пациента с ТЭЛА ..."
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
 
Vol 8, No 2 (2012) SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY Abstract  similar documents
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa
"... Цель. Изучить прогностическое значение синкопе при немассивной тромбоэмболии легочной артерии ..."
 
Vol 2, No 3 (2006) EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS Abstract  similar documents
A. P. Momot, O. V. Bespalova, E. N. Vorobyova
 
Vol 19, No 5 (2023) Non-immunogenic staphylokinase in the treatment of high-risk massive pulmonary embolism in the early postoperative period due to femoral fragment wound Abstract  similar documents
S. L. Konstantinov, G. I. Stryabkova, A. I. Basarab, V. N. Kravchuk, I. V. Kаzhanov, S. V. Ivanov, Zh. Yu. Chefranova, S. S. Markin
"... (Фортелизин®) в дозе 15 мг болюсно в течение 15 с у пациента с массивной тромбоэмболией легочной артерии (ТЭЛА ..."
 
Vol 17, No 3 (2021) Thrombolytic Therapy in Treatment in Patients with Pulmonary Embolism not High-risk: SIRENA Registry Data Abstract  similar documents
N. A. Cherepanova, I. S. Mullova, T. V. Pavlova, A. D. Erlikh, O. L. Barbarash, S. A. Berns, E. A. Schmidt, D. V. Duplyakov
"... тромбоэмболией легочной артерии (ТЭЛА) в реальной клинической практике российских стационаров. Материал и методы ..."
 
Vol 16, No 6 (2020) Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism Abstract  similar documents
A. A. Klimenko, N. A. Demidova, N. A. Shostak, M. O. Anischenko
"... После перенесенной тромбоэмболии легочной артерии (ТЭЛА) врачи сталкиваются с различными ..."
 
Vol 7, No 2 (2011) PATHOGENETIC MECHANISMS AND TREATMENT PRINCIPLES OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION Abstract  similar documents
N. A. Shostak, A. A. Klimenko, N. A. Demidova, I. V. Novikov
 
Vol 10, No 4 (2014) OPTIMAL PREVENTION OF HOSPITAL VENOUS THROMBOEMBOLISM WITH THE HELP OF MEDICAL INFORMATION SYSTEM Abstract  similar documents
G. I. Nazarenko, S. A. Payushk, V. A. Otdelenov, E. B. Kleymenova, L. P. Yashina, D. A. Sychev
"... Тромбоз глубоких вен и тромбоэмболия легочной артерии представляют собой важнейшую медико ..."
 
Vol 16, No 3 (2020) Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue Abstract  similar documents
O. D. Ostroumova, I. V. Goloborodova
 
Vol 16, No 2 (2020) The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment Abstract  similar documents
К. V. Lobastov, I. V. Schastlivtsev
"... (VTE) in cancer patients. In accordance with actual guidelines, the duration of anticoagulant therapy ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... This article affects  the problems of using NOAC in the most defenseless groups  of patients ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
 
Vol 20, No 4 (2024) Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? Abstract  similar documents
N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva
"... ) and venous thromboembolic complications (VTE) should be avoided in favor of safer alternative anticoagulants ..."
 
Vol 9, No 3 (2013) REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY Abstract  similar documents
A. A. Klimenko, N. A. Shostak, N. A. Demidova, I. V. Novikov, S. M. Sorokoletov, S. V. Madoyan
"... ). Материал и методы. В исследование включены 79 пациентов, перенесших тромбоэмболию легочной артерии (ТЭЛА ..."
 
Vol 17, No 3 (2021) Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey Abstract  similar documents
K. V. Lobastov, A. R. Navasardyan, I. V. Schastlivtsev
"... Aim. To assess the duration of the anticoagulant treatment of venous thromboembolism (VTE ..."
 
Vol 15, No 6 (2019) Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation Abstract  similar documents
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..."
 
Vol 20, No 6 (2024) Myocardial infarction of the "forgotten chamber of the heart" — the right atrium: a clinical case Abstract  similar documents
N. I. Kornev, K. G. Pereverzeva, S. S. Yakushin, I. B. Glukhovets
"... конечностей. Тромбоэмболия легочной артерии возникла вследствие тромбоза глубоких вен нижних конечностей и ..."
 
Vol 17, No 4 (2021) Changes in anticoagulant prescription in a general hospital in 2008-2018 Abstract  similar documents
E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev
"... oral anticoagulants (DOAC) prescription in clinical guidelines for venous thromboembolism (VTE) and AF ..."
 
Vol 20, No 5 (2024) Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials Abstract  similar documents
E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev
"... oral anticoagulants" or "direct oral anticoagulants" or "novel oral anticoagulant" or "NOAC" or "DOAC ..."
 
Vol 21, No 1 (2025) Practical aspects of perioperative management in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants Abstract  similar documents
E. N. Markova, T. Yu. Vedenikin, A. A. Kuzub, N. V. Kuchieva, A. R. Navasardyan, O. N. Dzhioeva
"... and hemorrhagic complications, and the need for venous thromboembolism (VTE) prophylaxis. Special attention ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... сутки превосходил варфарин по эффективности в профилактике инсульта и системных тромбоэмболий и не ..."
 
Vol 17, No 2 (2021) Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions Abstract  similar documents
V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto
"... (2,0-3,0) was in 111/281 (39,5%) patients. 57,7% (384/665) outpatients with AF received NOAC ..."
 
Vol 16, No 5 (2020) Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage Abstract  similar documents
N. B. Perepech, I. E. Mikhailova, A. V. Tregubov
"... тромбоэмболий. Только 24,4% терапевтов считают возможным назначить ривароксабан в дозе 2,5 мг 2 р/сут пациенту ..."
 
Vol 14, No 4 (2018) Elderly Patient Management Problems: Antithrombotic Therapy Selection Features. Clinical Case Abstract  similar documents
D. U. Akasheva, E. S. Bulgakova, I. S. Yavelov, A. Yu. Gorshkov, O. M. Drapkina
"... , венозные тромбоэмболии, фибрилляция предсердий) встречаются у них намного чаще, чем у более молодых. У этих ..."
 
Vol 19, No 2 (2023) Rendu-Osler-Weber Disease with High Pulmonary Hypertension and Interstitial Lung Disease Abstract  similar documents
Yu. A. Lutokhina, O. V. Blagova, P. O. Savina, E. V. Zaklyazminskaya
"... желудочка сохранна, однако присутствовала высокая легочная гипертензия. Данных за тромбоэмболию легочной ..."
 
Vol 16, No 3 (2020) Thrombosis of Prosthetic Cardiac Valve: Difficulties of Diagnostics on the Example of a Clinical Case with Lethal Outcome Abstract  similar documents
A. A. Novoselova, S. S. Yakushin
"... приходилось исключать тромбоэмболию легочной артерии и острый коронарный синдром. При этом была недооценена ..."
 
Vol 18, No 1 (2022) Cerebrovascular Accident in a Patient with Polycythemia: a Case Report Abstract  similar documents
O. M. Drapkina, I. I. Almazova, A. V. Smirnova, S. A. Berns, R. N. Shepel
"... конечностей, тромбоэмболией легочной артерии, тромбозом вен внутренних органов и другими состояниями. Одним из ..."
 
Vol 17, No 5 (2021) Gastrointestinal Bleeding: a Cardiologist's Point of View Abstract  similar documents
O. V. Averkov, L. N. Mishchenko
"... лечения тромбоэмболических состояний: при фибрилляции предсердий, тромбозе глубоких вен/тромбоэмболии ..."
 
Vol 18, No 5 (2022) Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova
"... тромбоза глубоких вен и тромбоэмболии легочной артерии. Настороженность в отношении побочных эффектов, как ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"...  проведении терапии антикоагулянтами для профилактики ишемического инсульта и системных тромбоэмболий. Однако ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... профилактики инсульта и системных тромбоэмболий у пациентов с фибрилляцией предсердий (ФП). Цель. Оценить ..."
 
Vol 14, No 5 (2018) Myocardial Infarction with Nonobstructive Coronary Arteries (МINОСА) – a Trendy Term or a New Diagnostic Concept? Abstract  similar documents
S. S. Yakushin
"... , миокардиты) и некардиальными (тромбоэмболия легочных артерий,  тромбофилии) заболеваниями. При анализе ..."
 
Vol 17, No 2 (2021) Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage Abstract  similar documents
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov
"... требует назначения антикоагулянтов с целью профилактики системных тромбоэмболий, и развитие ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... фибрилляции предсердий, с одной стороны, приводит к повышенному риску тромбоэмболии, а с другой – к увеличению ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... предсердий и высоким риском тромбоэмболии от приема пероральных антикоагулянтов 88,4% врачей считают ..."
 
Vol 16, No 5 (2020) Pharmacokinetics and Pharmacogenetics of Apixaban Abstract  similar documents
A. V. Savinova, M. M. Petrova, N. A. Shnayder, E. N. Bochanova, R. F. Nasyrova
"... фибрилляции предсердий, лечения тромбоза глубоких вен и тромбоэмболии легочной артерии. Его основной механизм ..."
 
Vol 16, No 5 (2020) Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov
"... , эндокардит, миокардит, перикардит, тромбоэмболия легочной артерии, наличие протеза сердечного клапана ..."
 
Vol 17, No 2 (2021) Laboratory predictors of clinical outcomes in patients with atrial fibrillation Abstract  similar documents
A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov
"... риском развития инсульта и системных тромбоэмболии. В последние годы для расширения возможности ..."
 
Vol 15, No 3 (2019) The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
"... случаях была ИБС (2 ОИМ, 1 аневризма левого желудочка); у 1 пациента – тромбоэмболия легочной артерии; 1 ..."
 
Vol 17, No 5 (2021) Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias Abstract  similar documents
O. V. Blagova, A. V. Nedostup, E. A. Kogan
"... антиаритмическим средствам. Два пациента (без РЧА) умерли от ишемического инсульта/тромбоэмболии легочной артерии ..."
 
Vol 19, No 6 (2023) Endovenous laser ablation of great saphenous vein and pharmacotherapy of acute ascending thrombophlebitis: results of a three-month follow-up Abstract  similar documents
K. A. Kaperiz, A. O. Rastatueva, I. S. Yavelov, O. M. Drapkina
"... фасции, распространения тромбоза на глубокие вены, тромбоэмболии легочных артерий не отмечено. В ..."
 
1 - 80 of 80 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)